Tag: Vedanta Biosciences

July 1, 2019 Off

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study

First clinical study of a rationally-defined bacterial consortium (VE416) for treating food allergy, will initially be studied in patients with history of peanut allergy

March 16, 2016 Off

PureTech’s Vedanta Biosciences Appoints New Chief Scientific Officer and Expands to New Facility

By Dino Mustafić

PureTech Health plc has announced the appointment of immunology expert and former Genzyme group vice president, Bruce L. Roberts, Ph.D., as Chief Scientific Officer.